ESMO Virtual Advanced Course on KRAS Targeting in NSCLC 2021

Learning objectives

• Understanding the function and biology of KRAS in normal and malignant cells
• Gaining insights in the spectrum of KRAS molecular aberrations, platforms and strategies for molecular testing
• In depth discussion of emerging therapeutic strategies and clinical research in KRAS mutated NSCLC
• Presenting novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of KRAS G12C inhibition and beyond

Download the programme

Accreditation

The programme of this event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to  ESMO-MORA Recertification Process & Requirements.

Co-Chairs

• Marina C. Garassino, United States
• Natasha Leighl, Canada